Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial
Authors
Cuiyun Li (ORCID: https://orcid.org/0000-0002-6306-2394)
Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial
Cuiyun Li, Qingfeng Dong, Jia Xu, Zhi‐Jie Liu et al.
Journal
Frontiers in Pharmacology
Topics
Monoclonal and Polyclonal Antibodies Research
article
Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial